Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

2.

Fluorinated vs. Zwitterionic-Polymer Grafted Surfaces for Adhesion Prevention of the Fungal Pathogen Candida albicans.

Masotti E, Poma N, Guazzelli E, Fiaschi I, Glisenti A, Vivaldi F, Bonini A, Francesco FD, Tavanti A, Galli G, Martinelli E.

Polymers (Basel). 2020 Feb 10;12(2). pii: E398. doi: 10.3390/polym12020398.

3.

TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineages.

Bottai D, Frigui W, Sayes F, Di Luca M, Spadoni D, Pawlik A, Zoppo M, Orgeur M, Khanna V, Hardy D, Mangenot S, Barbe V, Medigue C, Ma L, Bouchier C, Tavanti A, Larrouy-Maumus G, Brosch R.

Nat Commun. 2020 Feb 4;11(1):684. doi: 10.1038/s41467-020-14508-5.

4.

CpALS4770 and CpALS4780 contribution to the virulence of Candida parapsilosis.

Zoppo M, Di Luca M, Franco M, Rizzato C, Lupetti A, Stringaro A, De Bernardis F, Schaudinn C, Barrasa MI, Bottai D, Vyas VK, Tavanti A.

Microbiol Res. 2020 Jan;231:126351. doi: 10.1016/j.micres.2019.126351. Epub 2019 Oct 18.

PMID:
31707298
5.

A CRISPR/Cas9-based strategy to simultaneously inactivate the entire ALS gene family in Candida orthopsilosis.

Zoppo M, Luca MD, Villarreal SN, Poma N, Barrasa MI, Bottai D, Vyas VK, Tavanti A.

Future Microbiol. 2019 Nov;14:1383-1396. doi: 10.2217/fmb-2019-0168. Epub 2019 Oct 29.

PMID:
31659913
6.

Characterization of the Candida orthopsilosis agglutinin-like sequence (ALS) genes.

Lombardi L, Zoppo M, Rizzato C, Bottai D, Hernandez AG, Hoyer LL, Tavanti A.

PLoS One. 2019 Apr 24;14(4):e0215912. doi: 10.1371/journal.pone.0215912. eCollection 2019.

7.

MALDI-TOF MS Applications to the Detection of Antifungal Resistance: State of the Art and Future Perspectives.

Florio W, Tavanti A, Ghelardi E, Lupetti A.

Front Microbiol. 2018 Oct 30;9:2577. doi: 10.3389/fmicb.2018.02577. eCollection 2018.

8.

CORT0C04210 is required for Candida orthopsilosis adhesion to human buccal cells.

Zoppo M, Lombardi L, Rizzato C, Lupetti A, Bottai D, Papp C, Gácser A, Tavanti A.

Fungal Genet Biol. 2018 Nov;120:19-29. doi: 10.1016/j.fgb.2018.09.001. Epub 2018 Sep 8.

PMID:
30205198
9.

Recent Advances and Ongoing Challenges in the Diagnosis of Microbial Infections by MALDI-TOF Mass Spectrometry.

Florio W, Tavanti A, Barnini S, Ghelardi E, Lupetti A.

Front Microbiol. 2018 May 29;9:1097. doi: 10.3389/fmicb.2018.01097. eCollection 2018.

10.

CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates.

Rizzato C, Poma N, Zoppo M, Posteraro B, Mello E, Bottai D, Lupetti A, Sanguinetti M, Tavanti A.

J Antimicrob Chemother. 2018 Jul 1;73(7):1815-1822. doi: 10.1093/jac/dky122.

PMID:
29635519
11.

Use of Amplification Fragment Length Polymorphism to Genotype Pseudomonas stutzeri Strains Following Exposure to Ultraviolet Light A.

Lombardi L, Zoppo M, Rizzato C, Egan CG, Scarpato R, Tavanti A.

Pol J Microbiol. 2017 Mar 30;66(1):107-111. doi: 10.5604/17331331.1234998.

PMID:
29359695
12.

The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters.

Fais R, Di Luca M, Rizzato C, Morici P, Bottai D, Tavanti A, Lupetti A.

Front Microbiol. 2017 Nov 13;8:2218. doi: 10.3389/fmicb.2017.02218. eCollection 2017.

13.

The synthetic killer peptide KP impairs Candida albicans biofilm in vitro.

Paulone S, Ardizzoni A, Tavanti A, Piccinelli S, Rizzato C, Lupetti A, Colombari B, Pericolini E, Polonelli L, Magliani W, Conti S, Posteraro B, Cermelli C, Blasi E, Peppoloni S.

PLoS One. 2017 Jul 13;12(7):e0181278. doi: 10.1371/journal.pone.0181278. eCollection 2017.

14.

Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11.

Morici P, Fais R, Rizzato C, Tavanti A, Lupetti A.

PLoS One. 2016 Nov 30;11(11):e0167470. doi: 10.1371/journal.pone.0167470. eCollection 2016.

15.

Targeted gene disruption in Candida parapsilosis demonstrates a role for CPAR2_404800 in adhesion to a biotic surface and in a murine model of ascending urinary tract infection.

Bertini A, Zoppo M, Lombardi L, Rizzato C, De Carolis E, Vella A, Torelli R, Sanguinetti M, Tavanti A.

Virulence. 2016;7(2):85-97. doi: 10.1080/21505594.2015.1112491. Epub 2015 Dec 2.

16.

Pushing the Limits of MALDI-TOF Mass Spectrometry: Beyond Fungal Species Identification.

Rizzato C, Lombardi L, Zoppo M, Lupetti A, Tavanti A.

J Fungi (Basel). 2015 Oct 16;1(3):367-383. doi: 10.3390/jof1030367. Review.

17.

Insights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agents.

Lombardi L, Maisetta G, Batoni G, Tavanti A.

Molecules. 2015 Apr 10;20(4):6319-41. doi: 10.3390/molecules20046319. Review.

18.

Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP.

De Carolis E, Hensgens LA, Vella A, Posteraro B, Sanguinetti M, Senesi S, Tavanti A.

Med Mycol. 2014 Feb;52(2):123-30. doi: 10.1093/mmy/myt009. Epub 2014 Jan 6.

PMID:
24577004
19.

Antifungal Activity of the Noncytotoxic Human Peptide Hepcidin 20 against Fluconazole-Resistant Candida glabrata in Human Vaginal Fluid.

Del Gaudio G, Lombardi L, Maisetta G, Esin S, Batoni G, Sanguinetti M, Senesi S, Tavanti A.

Antimicrob Agents Chemother. 2013 Sep;57(9):4314-4321. doi: 10.1128/AAC.00904-13. Epub 2013 Jun 24.

20.

Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity.

Bertini A, De Bernardis F, Hensgens LA, Sandini S, Senesi S, Tavanti A.

Int J Med Microbiol. 2013 Mar;303(2):98-103. doi: 10.1016/j.ijmm.2012.12.006. Epub 2013 Feb 9.

PMID:
23403338

Supplemental Content

Loading ...
Support Center